<DOC>
	<DOC>NCT01355380</DOC>
	<brief_summary>This is a registry of patients diagnosed with pulmonary arterial hypertension, scheduled for treatment with Ventavis. Typical clinical measures and quality of life will be prospectively followed in 12 months period.</brief_summary>
	<brief_title>Efficacy of Ventavis Used in Real-life Setting.</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Pulmonary arterial hypertension Age 18+ Patients newly treated with Ventavis or switched from sildenafil Retrospective documentation is not allowed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>Inhaled iloprost</keyword>
	<keyword>Quality of life</keyword>
</DOC>